Enovix (ENVX) EBT (2020 - 2026)

Enovix (ENVX) has reported EBT for 7 consecutive years, with -$43.5 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, EBT rose 3.57% year-over-year to -$43.5 million; the trailing twelve-month figure through Jul 2026 stood at -$171.0 million (down 36.19% YoY), and the FY2025 full-year result was -$157.9 million, up 29.48% from the prior year.
• EBT fell to -$43.5 million in Q3 2026 per ENVX's latest filing, from -$38.4 million in the prior quarter.
• Across five years, EBT topped out at -$16.2 million in Q4 2023 and bottomed at -$120.5 million in Q2 2024.
• Historically, EBT has averaged -$47.2 million across 5 years, with a median of -$41.0 million in 2026.
• The sharpest annual moves came in 2022 and 2023: EBT soared 76.81% in 2022, then plunged 193.06% in 2023.
• Over 5 years, EBT stood at -$31.9 million in 2022, then slumped by 89.99% to -$60.7 million in 2023, then soared by 40.17% to -$36.3 million in 2024, then advanced by 3.83% to -$34.9 million in 2025, then declined by 24.66% to -$43.5 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$43.5 million, -$38.4 million, and -$34.9 million for Q3 2026, Q2 2026, and Q4 2025 respectively.